(Allergan plc)

	AGN latest price $140.2100 (0.12%) ($138.7600 - $143.8600) on Fri. May. 17, 2019.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.6% (three month average)
RSI	38
Latest Price	$140.2100(0.12%)
Stocks Behave Similarly	Similar Stock List
Weekly Trend	AGN declines -2.8% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(48%)    XLV(47%)    ARKG(46%)    DIA(45%)    IVE(45%)
Factors Impacting AGN price	AGN will decline at least -0.8% in a week (0% probabilities).   VXX(-39%)    VIXM(-24%)    TLT(-23%)    IFRA(-18%)    GDX(-5%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.8% (StdDev 1.6%)
Hourly BBV	0 ()
Intraday Trend	1%

1 - 5 Day Possible Target	$133.45(-4.82%)
Resistance Level	$141.65
5 Day Moving Average	$137.6(1.9%)
10 Day Moving Average	$139.64(0.41%)
20 Day Moving Average	$141.65(-1.02%)
To recent high	-9%
To recent low	3.9%
Market Cap	$46.227b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed